Sector Chart PharmaEngine, Inc.

Stocks

4162

TW0004162003

Biotechnology & Medical Research

End-of-day quote Taipei Exchange 2026-09-14			5-day change	1st Jan Change
54.10 ^TWD	+0.19%		-6.40%	-23.15%

08-06	PharmaEngine, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026	CI
05-12	PharmaEngine, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026	CI

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes

Sector Other Biotechnology & Medical Research

	Capi.	Sales Growth	Profitability	Finances	EV / Sales	P/E
PHARMAENGINE, INC.	245M	-	-	-	-	-
LONZA GROUP AG	45.48B
REVOLUTION MEDICINES, INC.	43.68B	-	-	-	-	-
IQVIA HOLDINGS INC.	43.09B
BEONE MEDICINES AG	39.4B
CELLTRION, INC.	31.91B